Regulation of bone turnover by calcium-regulated calcium channels

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 351-357

  Robinson, Lisa J ^a   Blair, Harry C ^a   Barnett, John B ^b   Zaidi, Mone ^c   Huang, Christopher L H ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Calcium channels; Inositol tris phosphate receptors; Osteoclasts; Ryanodine receptors

Indexed keywords

CAFFEINE; CALCIUM; CALCIUM CHANNEL; CALCIUM ION; CALMODULIN; CALPAIN; CD14 ANTIGEN; CD38 ANTIGEN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; CYCLIC AMP; CYCLIC GMP; DIACYLGLYCEROL; GUANYLATE CYCLASE; INOSITOL 1,4,5 TRISPHOSPHATE; MESSENGER RNA; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PERCHLORATE; PHOSPHODIESTERASE; PHOSPHOLIPASE C GAMMA; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RAPAMYCIN; RGS PROTEIN; RUTHENIUM RED; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; VANILLOID RECEPTOR 5;

AMINO TERMINAL SEQUENCE; APOPTOSIS; BONE MARROW; BONE TURNOVER; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ADHESION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOTILITY; CONFERENCE PAPER; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA VIRUS; LYMPHOID CELL; MACROPHAGE; MALIGNANT HYPERTHERMIA; MONOCYTE; MYOPATHY; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN BLOTTING;

EID: 77950650977     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05219.x     Document Type: Conference Paper

References (38)

1. Radding, W. et al. 1999. Intracellular calcium puffs in osteoclasts. Exp. Cell Res. 253: 689-696.
2. Foskett, J.K. et al. 2007. Inositol trisphosphate receptor Ca2+ release channels. Physiol. Rev. 87: 593-655.
3. Dellis, O. et al. 2006. Ca2+ entry through plasma membrane IP3 receptors. Science 313: 229-233.
4. Vermassen, E. et al. 2004. Subcellular distribution of the inositol-1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol. Cell 96: 3-17.
5. Morikawa, K. et al. 2008. Distribution of inositol 1,4,5- trisphosphate receptors in rat osteoclasts. Acta Histochem. Cytochem. 41: 7-13.
6. Kuroda, Y. et al. 2008. Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis. Proc. Natl. Acad. Sci. USA 105: 8643-8648.
7. Yaroslavskiy, B.B. et al. 2007. Necessity of inositol (1,4,5)-trisphosphate receptor-1 and μ calpain in NOinduced osteoclast motility. J. Cell Sci. 120: 2884-2894.
8. Blair, H.C. et al. 2007. Calcium signalling and calcium transport in bone disease. Subcell. Biochem. 45: 539-562.
9. Mentaverri, R. et al. 2006. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J. 20: E1945-1954.
10. Xie, Y.C. et al. 1997. Inhibitory effect of 3,4- dichloropropionaniline on cytokine production by macrophages is associated with LPS-mediated signal transduction. J. Leukoc. Biol. 61: 745-752.
11. Koga, T. et al. 2004. Costimulatory signals mediated by the ITAMmotif cooperate with RANKL for bone homeostasis. Nature 428: 758-763.
12. Yang, S. & Y.P. Li. 2007. RGS12 is essential for RANKLevoked signaling for terminal differentiation of osteoclasts in vitro. J. Bone Miner. Res. 21: 45-54.
13. Yaroslavskiy, B.B. et al. 2005. NO-dependent osteoclast motility: reliance on cGMP dependent protein kinase I and VASP. J Cell Sci. 118: 5479-5487.
14. Cui, J. et al. 2004. Regulation of the type 1 inositol 1,4,5- trisphosphate receptor by phosphorylation at tyrosine 353. J. Biol. Chem. 279: 16311-16316.
15. DeSouza, N. et al. 2007.Afunction for tyrosine phosphorylation of type 1 inositol 1,4,5 trisphosphate receptor in lymphocyte activation. J. Cell Biol. 179: 923-934.
16. Murthy, K.S. & H. Zhou. 2003. Selective phosphorylation of the IP3R-I in vivo by cGMP dependent protein kinase in smooth muscle. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G221-G230.
17. Schlossmann, J. et al. 2000. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ. Nature 404: 197-201.
18. MacMillan, D. et al. 2005. In smooth muscle, FK506- binding protein modulates IP3 receptor evoked Ca2+ release by mTOR and calcineurin. J. Cell Sci. 118: 5443-5451.
19. DeSouza N. et al. 2002. Protein kinase A and two phosphatases are components of the inositol 1,4,5- trisphosphate receptor macromolecular signaling complex. J. Biol. Chem. 277: 39397-39400.
20. Shaughnessy J.D., Jr. et al. 1999. Mrvi1, a commonMRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1. Oncogene 18: 2069-2084.
21. Ammendola A. et al. 2001. Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Iβ. J. Biol. Chem. 276: 24153-24159.
22. Fritsch R.M. et al. 2004. InsP3R-associated cGMP kinase substrate (IRAG) is essential for nitric oxide-induced inhibition of calcium signaling in humancolonic smooth muscle. J. Biol. Chem. 279: 12551-12559.
23. Casteel D.E. et al. 2008. cGMP-dependent protein kinase anchoring by IRAG regulates its nuclear translocation and transcriptional activity. Cell Signal. 20: 1392-1399.
24. Antl M. et al. 2007. IRAG mediates NO/cGMPdependent inhibition of platelet aggregation and thrombus formation. Blood 109: 552-559.
25. Zalk, R. et al. 2007.Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 76: 367-385.
26. Zaidi, M. et al. 1995. A ryanodine receptor-likemolecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing. J. Clin. Invest. 96: 1582-1590.
27. Moonga, B.S. et al. 2002. Ca2+ influx through the osteoclastic plasma membrane ryanodine receptor. Am. J. Physiol. Renal Physiol. 282: F921-F932.
28. Zaidi, M. et al. 1992. Evidence that a ryanodine receptor triggers signal transduction in the osteoclast. Biochem. Biophys. Res. Comm. 188: 1332-1336.
29. Adebanjo,O.A. et al. 1996. Extracellularly applied ruthenium red and cADP ribose elevate cytosolic Ca2+ in isolated rat osteoclasts. Am. J. Physiol. 270: F469- 475'
30. Shankar,V. S. et al. 1995.Caffeine modulatesCa2+ receptor activation in isolated rat osteoclasts and induces intracellular Ca2+ release. Am. J. Physiol. 268: F447-F454.
31. Zaidi, M. et al. 1992. A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationship with cellular function. Eur. J. Biophys. 21: 349-355.
32. Zaidi, M. et al. 2004. Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption. Biol. Rev. Camb. Philos. Soc. 79: 79-100.
33. Braun, A. et al. 2009. STIM1 is essential for Fcγ receptor activation and autoimmune inflammation. Blood 113: 1097-1104.
34. Putney, J.W. 2007. Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on howwe got here).Cell. Calcium42: 103-110.
35. Feske, S. 2007. Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 7: 690-702.
36. Mentaverri, R. et al. 2003. Involvement of capacitive calcium entry and calcium store refilling in osteoclastic survival and bone resorption process. Cell. Calcium 34: 169-175.
37. Van Der Eerden, B.C. et al. 2005. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc.Natl. Acad. Sci.USA 102: 17507-17512.
38. Huang, C.L. et al. 2007. Similarities and contrasts in ryanodine receptor localization and function in osteoclasts and striatedmuscle cells. Ann. N.Y. Acad. Sci. 1116: 255-270.